| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | - | 0 | 28.653 | 36.466 | 0 |
| Total Income - EUR | - | - | - | - | - | - | 338 | 31.483 | 73.861 | 0 |
| Total Expenses - EUR | - | - | - | - | - | - | 6.556 | 56.139 | 72.469 | 0 |
| Gross Profit/Loss - EUR | - | - | - | - | - | - | -6.218 | -24.656 | 1.392 | 0 |
| Net Profit/Loss - EUR | - | - | - | - | - | - | -6.218 | -25.274 | 654 | 0 |
| Employees | - | - | - | - | - | - | 0 | 1 | 1 | 0 |
Check the financial reports for the company - Premiere Vet Pharm S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | - | 23.225 | 47.890 | 41.013 | 0 |
| Current Assets | - | - | - | - | - | - | 11.663 | 35.583 | 71.533 | 0 |
| Inventories | - | - | - | - | - | - | 5.615 | 22.179 | 47.328 | 0 |
| Receivables | - | - | - | - | - | - | 5.883 | 13.745 | 20.999 | 0 |
| Cash | - | - | - | - | - | - | 165 | -341 | 3.206 | 0 |
| Shareholders Funds | - | - | - | - | - | - | -6.178 | -31.471 | -30.722 | 0 |
| Social Capital | - | - | - | - | - | - | 40 | 41 | 40 | 0 |
| Debts | - | - | - | - | - | - | 41.066 | 114.944 | 143.268 | 0 |
| Income in Advance | - | - | - | - | - | - | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4773 - 4773" | |||||||||
| CAEN Financial Year |
4773
|
|||||||||
Comments - Premiere Vet Pharm S.r.l.